Nanobodies Targeting Mouse/Human VCAM1 for the Nuclear Imaging of Atherosclerotic Lesions
暂无分享,去创建一个
Jakub Toczek | S. Muyldermans | N. Thielens | U. Wernery | N. Devoogdt | A. Broisat | S. Hernot | J. De Vos | L. Riou | Sandrine Martin | M. Ahmadi | V. Caveliers | T. Lahoutte | D. Fagret | C. Ghezzi | Jens De Vos
[1] Jakub Toczek,et al. Nanobody-coupled microbubbles as novel molecular tracer. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[2] W. Mali,et al. Rapid Visualization of Human Tumor Xenografts through Optical Imaging with a Near-Infrared Fluorescent Anti–Epidermal Growth Factor Receptor Nanobody , 2012, Molecular imaging.
[3] S. Muyldermans,et al. Preclinical screening of anti‐HER2 nanobodies for molecular imaging of breast cancer , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[4] U. Tuor,et al. Small unilamellar vesicles: a platform technology for molecular imaging of brain tumors , 2011, Nanotechnology.
[5] G. V. van Dongen,et al. Facile labelling of an anti-epidermal growth factor receptor Nanobody with 68Ga via a novel bifunctional desferal chelate for immuno-PET , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[6] H. Saji,et al. Tissue Factor Detection for Selectively Discriminating Unstable Plaques in an Atherosclerotic Rabbit Model , 2010, The Journal of Nuclear Medicine.
[7] H. Saji,et al. Imaging with radiolabelled anti-membrane type 1 matrix metalloproteinase (MT1-MMP) antibody: potentials for characterizing atherosclerotic plaques , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[8] S. Muyldermans,et al. In Vitro Analysis and In Vivo Tumor Targeting of a Humanized, Grafted Nanobody in Mice Using Pinhole SPECT/Micro-CT , 2010, Journal of Nuclear Medicine.
[9] Jie Pan,et al. Lack of apoE causes alteration of cytokines expression in young mice liver , 2010, Molecular Biology Reports.
[10] H. Revets,et al. The development of nanobodies for therapeutic applications. , 2009, Current opinion in investigational drugs.
[11] Ralph Weissleder,et al. 18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis. , 2009, JACC. Cardiovascular imaging.
[12] J. Wykrzykowska,et al. Imaging of Inflamed and Vulnerable Plaque in Coronary Arteries with 18F-FDG PET/CT in Patients with Suppression of Myocardial Uptake Using a Low-Carbohydrate, High-Fat Preparation , 2009, Journal of Nuclear Medicine.
[13] J. Dimastromatteo,et al. Pre-clinical and clinical evaluation of nuclear tracers for the molecular imaging of vulnerable atherosclerosis: an overview. , 2009, Current medicinal chemistry.
[14] C. R. Leemans,et al. Improved tumor targeting of anti–epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology , 2008, Molecular Cancer Therapeutics.
[15] Christian Vanhove,et al. Comparison of the Biodistribution and Tumor Targeting of Two 99mTc-Labeled Anti-EGFR Nanobodies in Mice, Using Pinhole SPECT/Micro-CT , 2008, Journal of Nuclear Medicine.
[16] J. Lindner,et al. Molecular Imaging of Inflammation in Atherosclerosis With Targeted Ultrasound Detection of Vascular Cell Adhesion Molecule-1 , 2007, Circulation.
[17] D. Boturyn,et al. Molecular imaging of vascular cell adhesion molecule-1 expression in experimental atherosclerotic plaques with radiolabelled B2702-p , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[18] Ralph Weissleder,et al. Noninvasive Vascular Cell Adhesion Molecule-1 Imaging Identifies Inflammatory Activation of Cells in Atherosclerosis , 2006, Circulation.
[19] J. Knuuti,et al. Non-specific binding of [18F]FDG to calcifications in atherosclerotic plaques: experimental study of mouse and human arteries , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[20] L. Wyns,et al. Identification of a universal VHH framework to graft non-canonical antigen-binding loops of camel single-domain antibodies. , 2005, Journal of molecular biology.
[21] Zahi A Fayad,et al. Atherothrombosis and high-risk plaque: part I: evolving concepts. , 2005, Journal of the American College of Cardiology.
[22] A. Lew,et al. Antigen targeted to secondary lymphoid organs via vascular cell adhesion molecule (VCAM) enhances an immune response. , 2003, Vaccine.
[23] Howard T. Petrie,et al. Characterization of Vascular Adhesion Molecules that may Facilitate Progenitor Homing in the Post-natal Mouse Thymus , 2003, Clinical & developmental immunology.
[24] J. Pickard,et al. Imaging Atherosclerotic Plaque Inflammation With [18F]-Fluorodeoxyglucose Positron Emission Tomography , 2002, Circulation.
[25] S. Nilsson,et al. Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. , 2001, Blood.
[26] K. Ley,et al. Adhesion molecules and atherogenesis. , 2001, Acta physiologica Scandinavica.
[27] M. Cybulsky,et al. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. , 1999, Circulation research.
[28] K. Williams,et al. Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.
[29] L. Wyns,et al. Selection and identification of single domain antibody fragments from camel heavy‐chain antibodies , 1997, FEBS letters.
[30] E. Shevach,et al. Vascular cell adhesion molecule-1 is expressed by cortical thymic epithelial cells and mediates thymocyte adhesion. Implications for the function of alpha4beta1 (VLA4) integrin in T-cell development. , 1997, Blood.
[31] M. A. Borrello,et al. Differential Thy-1 expression by splenic fibroblasts defines functionally distinct subsets. , 1996, Cellular immunology.
[32] C. Alpers,et al. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. , 1996, Circulation.
[33] M. Ferguson,et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. , 1993, The Journal of clinical investigation.
[34] R. Tizard,et al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes , 1989, Cell.
[35] B. Engelhardt,et al. Immunobiology: Comprehensive analysis of lymph node stroma-expressed Ig superfamily members reveals redundant and nonredundant roles for ICAM-1, ICAM-2, and VCAM-1 in lymphocyte homing , 2012 .
[36] Paul,et al. Adhesion receptors on bone marrow stromal cells: in vivo expression of vascular cell adhesion molecule-1 by reticular cells and sinusoidal endothelium in normal and gamma-irradiated mice. , 1996, Blood.
[37] C. E. van der Schoot,et al. Constitutive expression of E-selectin and vascular cell adhesion molecule-1 on endothelial cells of hematopoietic tissues. , 1996, The American journal of pathology.
[38] D. G. Osmond,et al. Adhesion receptors on bone marrow stromal cells: in vivo expression of vascular cell adhesion molecule-1 by reticular cells and sinusoidal endothelium in normal and gamma-irradiated mice , 1996 .